Non-Vascular Stents Market Outlook (2022-2032)

[315 Pages Report] During the projected timeframe, the non-vascular stents market is predicted to increase at a CAGR of 4.5%. (2022 - 2032). The industry is anticipated to be worth US$ 1.21 Billion in 2022, rising to US$ 1.9 Billion by 2032.

Over the forthcoming years, the global non-vascular stents market is going to expand remarkably in response to the increasing demand for less invasive methodologies. Several obvious factors contributing to market growth during the forecast period are mentioned below

  • Current emerging and material advancements have aided in the development of custom-made stents for a wide range of conditions.
  • Polyacrylic amine and polylactic acid-glycolic acid are two recently developed biodegradable stent materials that do not necessitate stent withdrawal.
  • Favorable government proposals to be utilized for such medical devices, as well as rising costs of healthcare.
  • Prolonged research and development attempts to enhance stent materials, designs, and minimally invasive stenting procedures using endoscopes.
  • A rise in demand for patients undergoing minimally invasive operations as a consequence of shortened methodology times and lower costs in ambulatory surgical centers.

During the pandemic period, COVID-19 is anticipated to have a significant impact on market growth. The volume of invasive procedures has decreased significantly during the global epidemic, owing to regulatory authorities' strict guidelines to avoid all non-emergent surgeries.

According to a National Institute of Health article published in October 2021 titled "The impact of COVID-19 on emergency general surgery admissions and operative volumes: A single-center experience,". As a result, COVID-19 has had a major effect on the market for non-vascular stent devices.

Attributes Details
Non-Vascular Stents Market CAGR (2022 to 2032) 4.5%
Non-Vascular Stents Market Value (2022) US$ 1.21 Billion
Non-Vascular Stents Market Value (2032) US$ 1.9 Billion

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

The Asia Pacific and Europe are projected to offer the Largest Opportunity for Non-Vascular Stents Market

During the forthcoming years, the US is anticipated to dominate the non-vascular market with a CAGR of 3.9%, generating a revenue of US$ 659.1 Million by 2032.

In the United States, COPD, lung cancer, central respiratory failure, glaucoma, bronchitis, and other chronic diseases are becoming more prevalent. The appearance of a target population, significant market players, and good healthcare infrastructural facilities in the region all contributed to the region's considerable market share for the United States.

These rising interest rates of emergent incisional hernia repair are concerning because they carry a significantly increased risk of morbidity and mortality, requiring the adoption of gastrointestinal stents in the United States. Cook Medical launched the Evolution Biliary Controlled-Release Uncovered Stent in the United States. This stent is used to unclog obstructed bile ducts.

Europe is also expected to retain a major market share during the forecast time frame due to the EU5 countries' prospering medical technology industry and increased incidence of gastric cancer.

The Asia Pacific, on the other hand, is expected to experience a higher CAGR during the forecast period than most other regions due to favorable government initiatives for the adoption of such medical equipment, a growing geriatric population, and soaring healthcare infrastructure.

Market Growth will be driven by increasing developments by Key Manufacturers

The market for non-vascular stents is competitive, with a few major players. Becton, Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Cook Medical, ELLA - CS, s.r.o., Glaukos Corporation, Hobbs Medical., Medtronic, Micro-Tech (Nanjing) Co. Ltd, W. L. Gore & Associates Inc., and others hold a significant market share.

To increase market revenue and augment their corporation portfolio, they employ a variety of strategies, resulting in several emerging trends in the non-vascular stents market. As a result, these firms focus on a variety of growth strategies, including mergers and acquisitions patient awareness campaigns, and launches of new products.

"The global non-vascular stents market is likely to advance to a significant extent in response to the growing demand for minimally invasive procedures over the forecast period."

During the forecast period, the market growth is contributed by a few obvious factors, including an increase in the geriatric population, per capita healthcare spending, and the prevalence of chronic cancer and other diseases.

Moreover, with rapid technological advancements, the non-vascular stents market trends are expected to gain momentum and grow at a healthy rate throughout the forecast period.

Non-vascular stents use precise, small incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy. Such surgery is associated with a faster recovery period, resulting in a shorter hospital stay for the patient, encouraging many to opt for the same, in turn, surging the adoption of non-vascular stents.

Furthermore, sales of non-vascular stents are likely to surge as patients are less likely to contract hospital-acquired illnesses like bloodstream infections and urinary tract infections if they stay in the hospital for a shorter period of time.

In recent years, non-vascular stents have become the proper standard for removing occluding malignancies in the gastrointestinal tract and hence, providing impetus to the non-vascular stents market size to a significant extent.

Emerging technological and material breakthroughs have been assisting in the development of specially tailored stents for use in a variety of indications, resulting in increased demand for non-vascular stents in a variety of applications.

The discovery of biodegradable plastics, as well as bio-absorbable scaffolds, has spiked the use of stents in gastrointestinal, urological, biliary strictures, and pulmonary, greatly influencing the non-vascular stents market demand analysis.

The non-vascular stents market outlook is positively impacted by the newly developed biodegradable stent materials that do not require stent removal, polyacrylic amine and polylactic acid-glycolic acid being a couple of them.

On account of its high elasticity, nitinol is increasingly being used in non-vascular self-expandable stents, making it ideal for stent implantation in difficult internal tract segments.

The market is predicted to be aided by favourable government initiatives to be used for such medical devices and rising healthcare expenditure.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Various Factors Impacting the Non-Vascular Stents Market?

The proliferation of hospitals and ambulatory surgical centers and increasing healthcare spending in developing countries are providing impetus to the non-vascular stents market growth.

The market is also positively impacted by the government and private insurance companies' medical reimbursement policies that are beneficial.

Continuous R&D efforts to develop much better stent materials, designs, and minimally invasive stenting procedures utilizing endoscopes are likely to bring about non-vascular stent market future trends.

On the other hand, the high cost of metallic stents is declining the sales of non-vascular stents and dwindling the overall market.

Governments and regulatory bodies around the world are constantly revising healthcare reforms to improve the quality of medical devices while also lowering their costs is posing a challenge to the global non-vascular stents market.

The market for non-vascular stents is likely to be hampered by the availability of alternative treatment options for treating luminal strictures.

Furthermore, government, as well as regulatory pressure to reduce the cost of medical devices, as well as the presence of a large number of domestic players in most regions are likely to impede the non-vascular stents market trends and forecasts.

The development of drug-eluting stents, biodegradable stents, and radioactive stents creates a wide array of non-vascular stents market opportunities in the near future.

Demonstrating long-term efficacy and medical device excise taxes are some of the other major roadblocks to the non-vascular stents market.

Comparative View of Adjacent Non-Vascular Stents Market

Non-Vascular Stents Market:

Attributes Non-Vascular Stents Market
CAGR (2022 to 2032) 4.5%
Market Value (2026) US$ 1.44 Billion
Growth Factor With rapid technological advancements, an ageing population, and rising cancer and urolithiasis rates, urolithiasis is becoming more common. In the forecast period, the market is expected to grow at a healthy rate.
Opportunity The development of drug-eluting stents, biodegradable stents, and radioactive stents creates huge stents market opportunities in the near future.
Key Trends Continuous R&D efforts to develop better stent materials, designs, and minimally invasive stenting procedures utilizing endoscopes.

Gastrointestinal Stents Market:

Attributes Gastrointestinal Stents Market
CAGR (2022 to 2032) 6%
Market Value (2026) US$ 600 Million
Growth Factor The rising preference for minimally invasive (MI) surgical procedures, is having a significant impact on the gastrointestinal stent market growth.
Opportunity Due to a significant increase in healthcare infrastructure and the implementation of favorable government regulations, market opportunities are expected to expand.
Key Trends Gastrointestinal stents market future trends are likely to be swayed by various technological advancements, such as the development of gastrointestinal biodegradable stents and nitinol material-based stents with a high degree of flexibility and kink-resistance.

Drug Eluting Stents Market:

Attributes Drug Eluting Stents Market
CAGR (2022 to 2032) 6.3%
Market Value (2026) US$ 9.5 Billion
Growth Factor Over the projected period, a major factor expected to drive the drug eluting stents market is the rising prevalence of peripheral arterial disease (PAD).
Opportunity The strategic expansion of manufacturers in the DES market is likely to be aided by robust research and development on cardiovascular interventions, as well as the introduction of bioresorbable polymer-based DES.
Key Trends One of the key trends in the drug eluting stents market is the development and introduction of fully bioresorbable polymers, the goal of which is to prevent restenosis, increase patient safety, and improve procedure clinical outcomes.

The global non-vascular stents market is moving forward due to ongoing innovation. Innovations regarding the non-vascular stents for the specialization of medical devices that helps in relieving the structures in the gastrointestinal tract, airway, and ureteral tract are happening, which are likely to set the tone for the market.

Most non-vascular stents companies work with a sense of urgency and customer focus in the post-pandemic era.

Efforts are being made to cut costs across the value chain so that products can be sold at competitive prices.

Furthermore, long-term success would be determined by continued innovation and customer-centric strategies, as well as modernizing and expanding manufacturing.

The flexibility of non-vascular stents has been increased owing to recent advancements in stent materials and drug coatings, such as the use of CoCr alloys in stents.

Stents coated with a drug like an immunosuppressive agent have been developed to prevent stent restenosis, and they are now widely used, thereby fostering the non-vascular stents key trends & opportunities.

In addition, the adoption of advanced technologies for stent deployment and retrieval is significantly aiding the market.

An inclination in demand for minimally invasive surgery patients due to shorter procedure times and lower costs in ambulatory surgical centres is expected also projected to drive demand for non-vascular stents during the forecast period.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Which Segment is Anticipated to Dominate the Non-Vascular Stents Market, by Product?

In terms of product, urological stents segment is likely to dominate the non-vascular stents market advancing at a CAGR of 4.3% from 2022 to 2032.

On account of the rising prevalence of ureteral diseases such as renal calculi or kidney stones, urinary tract infections, and prostate cancer around the world, the urological stents segment has emerged as the largest segment.

The demand for urological stents is expected to rise due to an increase in the number of ureterorenoscopy, ureteroscopy, lithotripsy, and schistosomiasis procedures performed around the world.

What is the Regional-Outlook for the Non-Vascular Stents Market?

Regions CAGR (2022 to 2032)
USA Market 3.9%
UK Market 3.3%
China Market 3.6%
Japan Market 3.9%
India Market 3.7%

During the projected period, the US is expected to lead the non-vascular market with a CAGR of 3.9% during the forecast period, garnering a revenue of US$ 659.1 million by 2032.

COPD, lung cancer, central airway obstruction, glaucoma, asthma, and other chronic diseases are becoming pervasive in the United States.

The presence of a target population, major market players, and a strong healthcare infrastructure in the region all contributed to the sizeable the US market share.

These rising rates of emergent incisional hernia repair are alarming as they carry a much higher risk of morbidity and mortality, necessitating the use of gastrointestinal stents in the United States.

The flourishing medical technology sector and the rising prevalence of gastric cancer in the UK are likely to contribute to the market size.

However, due to rising geriatric population, favourable government initiatives for the use of such medical devices, and rising healthcare expenditure, China and India are expected to grow at a faster rate than other regions over the forecast period.

Increased healthcare allocations, as well as an increase in the number of hospitals and day surgery centres can also be credited to the region’s major non-vascular stents market share.

What is the Competition Landscape in the Non-Vascular Stents Market?

The market for non-vascular stents is competitive, with only a few major players.

To augment market profit and diversify their company portfolio, they use a variety of strategies thereby bringing about various emerging trends in non-vascular stents market.

Hence, these companies concentrate on a variety of growth strategies, such as mergers and acquisitions, patient awareness campaigns, and new product launches.

Some of the recent developments in market are:

  • Medtronic acquired Medicrea, a fully dedicated spinal implant company focused on introducing reliable and cutting-edge technology to the global market.
  • Boston Scientific Corporation's third-generation drug-eluting stent (DES) technology is the TAXUS Element Paclitaxel-Eluting Coronary Stent System. This product is designed specifically for coronary stenting and combines strength and flexibility.
  • In the United States, Cook Medical introduced the Evolution Biliary Controlled-Release Uncovered Stent. This stent is used to clear clogged bile ducts.

Key Players

  • Medtronic plc.
  • Glaukos Corporation
  • Boston Scientific Corporation
  • ELLA - CS, s.r.o.
  • CONMED Corporation

Key Segments

By Product:

  • Gastrointestinal Stents
    • Biliary
    • Duodenal
    • Colonic
    • Pancreatic
    • Oesophageal Stents
  • Pulmonary Stents
    • Silicone Airway
    • Metallic Airway
  • Urological Stents
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Frequently Asked Questions

What is the CAGR of the Non-Vascular Stents Market?

The non-vascular stents market is projected to register a CAGR of 4.5% during the forecast period (2022 - 2032).

Which is the Leading Country in the Non-Vascular Stents Market?

During the forecast period, the US is expected to lead the non-vascular stents market accounting for US$ 659.1 million by 2032.

Which Segment Dominates the Non-Vascular Stents Market by Product?

Urological stents segment is expected to dominate the non-vascular stents market over the forecast period with a CAGR of 4.3% from 2022 to 2032.

What is the Estimated Non-Vascular Stents Market Size by 2032?

The non-vascular stents market is expected to be appraised at US$1.9 billion by 2032.

Which was the Historical Size of the Non-Vascular Stents Market?

The non-vascular stents market sized was valued at US$ 1.17 billion in 2021.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points

    4.1. Global Market (US$ Mn)

    4.2. Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Global Market Growth

        4.5.3. Adoption Rate, by Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Product

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Product, 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2032

        8.3.1. Gastrointestinal Stents

            8.3.1.1. Biliary

            8.3.1.2. Duodenal

            8.3.1.3. Colonic

            8.3.1.4. Pancreatic

            8.3.1.5. Esophageal Stents

        8.3.2. Pulmonary (Airway) Stents

            8.3.2.1. Silicone Airway

            8.3.2.2. Metallic Airway

        8.3.3. Urological Stents

        8.3.4. Others

    8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    9.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. Asia Pacific

        9.3.5. Middle East and Africa (MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2015-2021 and Forecast 2022-2032

    10.1. Introduction

    10.2. Pricing Analysis

    10.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    10.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        10.4.1. By Country

            10.4.1.1. U.S.

            10.4.1.2. Canada

        10.4.2. By Product

    10.5. Market Attractiveness Analysis

        10.5.1. By Country

        10.5.2. By Product

11. Latin America Market Analysis 2015-2021 and Forecast 2022-2032

    11.1. Introduction

    11.2. Pricing Analysis

    11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        11.4.1. By Country

            11.4.1.1. Brazil

            11.4.1.2. Mexico

            11.4.1.3. Rest of Latin America

        11.4.2. By Product

    11.5. Market Attractiveness Analysis

        11.5.1. By Country

        11.5.2. By Product

12. Europe Market Analysis 2015-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. Germany

            12.4.1.2. France

            12.4.1.3. U.K.

            12.4.1.4. Italy

            12.4.1.5. Benelux

            12.4.1.6. Nordic Countries

            12.4.1.7. Rest of Europe

        12.4.2. By Product

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Product

13. Asia Pacific Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. China

            13.4.1.2. Japan

            13.4.1.3. South Korea

            13.4.1.4. Rest of Asia Pacific

        13.4.2. By Product

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Product

14. Middle East and Africa Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. GCC Countries

            14.4.1.2. South Africa

            14.4.1.3. Turkey

            14.4.1.4. Rest of Middle East and Africa

        14.4.2. By Product

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product

15. Key Countries Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

        15.1.1. Market Value Proportion Analysis, By Key Countries

        15.1.2. Global Vs. Country Growth Comparison

    15.2. US Market Analysis

        15.2.1. Value Proportion Analysis by Market Taxonomy

        15.2.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.2.2.1. By Product

    15.3. Canada Market Analysis

        15.3.1. Value Proportion Analysis by Market Taxonomy

        15.3.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.3.2.1. By Product

    15.4. Mexico Market Analysis

        15.4.1. Value Proportion Analysis by Market Taxonomy

        15.4.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.4.2.1. By Product

    15.5. Brazil Market Analysis

        15.5.1. Value Proportion Analysis by Market Taxonomy

        15.5.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.5.2.1. By Product

    15.6. Germany Market Analysis

        15.6.1. Value Proportion Analysis by Market Taxonomy

        15.6.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.6.2.1. By Product

    15.7. France Market Analysis

        15.7.1. Value Proportion Analysis by Market Taxonomy

        15.7.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.7.2.1. By Product

    15.8. Italy Market Analysis

        15.8.1. Value Proportion Analysis by Market Taxonomy

        15.8.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.8.2.1. By Product

    15.9. BENELUX Market Analysis

        15.9.1. Value Proportion Analysis by Market Taxonomy

        15.9.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.9.2.1. By Product

    15.10. UK Market Analysis

        15.10.1. Value Proportion Analysis by Market Taxonomy

        15.10.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.10.2.1. By Product

    15.11. Nordic Countries Market Analysis

        15.11.1. Value Proportion Analysis by Market Taxonomy

        15.11.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.11.2.1. By Product

    15.12. China Market Analysis

        15.12.1. Value Proportion Analysis by Market Taxonomy

        15.12.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.12.2.1. By Product

    15.13. Japan Market Analysis

        15.13.1. Value Proportion Analysis by Market Taxonomy

        15.13.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.13.2.1. By Product

    15.14. South Korea Market Analysis

        15.14.1. Value Proportion Analysis by Market Taxonomy

        15.14.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.14.2.1. By Product

    15.15. GCC Countries Market Analysis

        15.15.1. Value Proportion Analysis by Market Taxonomy

        15.15.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.15.2.1. By Product

    15.16. South Africa Market Analysis

        15.16.1. Value Proportion Analysis by Market Taxonomy

        15.16.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.16.2.1. By Product

    15.17. Turkey Market Analysis

        15.17.1. Value Proportion Analysis by Market Taxonomy

        15.17.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.17.2.1. By Product

        15.17.3. Competition Landscape and Player Concentration in the Country

16. Market Structure Analysis

    16.1. Market Analysis by Tier of Companies

    16.2. Market Concentration

    16.3. Market Share Analysis of Top Players

    16.4. Market Presence Analysis

        16.4.1. By Regional footprint of Players

        16.4.2. Product footprint by Players

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Competition Deep Dive

        17.3.1. Medtronic plc

            17.3.1.1. Overview

            17.3.1.2. Product Portfolio

            17.3.1.3. Sales Footprint

            17.3.1.4. Strategy Overview

        17.3.2. Glaukos Corporation

            17.3.2.1. Overview

            17.3.2.2. Product Portfolio

            17.3.2.3. Sales Footprint

            17.3.2.4. Strategy Overview

        17.3.3. Boston Scientific Corporation

            17.3.3.1. Overview

            17.3.3.2. Product Portfolio

            17.3.3.3. Sales Footprint

            17.3.3.4. Strategy Overview

        17.3.4. ELLA - CS, s.r.o.

            17.3.4.1. Overview

            17.3.4.2. Product Portfolio

            17.3.4.3. Sales Footprint

            17.3.4.4. Strategy Overview

        17.3.5. CONMED Corporation

            17.3.5.1. Overview

            17.3.5.2. Product Portfolio

            17.3.5.3. Sales Footprint

            17.3.5.4. Strategy Overview

        17.3.6. HOBBS MEDICAL, INC;

            17.3.6.1. Overview

            17.3.6.2. Product Portfolio

            17.3.6.3. Sales Footprint

            17.3.6.4. Strategy Overview

        17.3.7. Cook Medical

            17.3.7.1. Overview

            17.3.7.2. Product Portfolio

            17.3.7.3. Sales Footprint

            17.3.7.4. Strategy Overview

        17.3.8. Taewoong Medical Co., Ltd.

            17.3.8.1. Overview

            17.3.8.2. Product Portfolio

            17.3.8.3. Sales Footprint

            17.3.8.4. Strategy Overview

        17.3.9. Synchron Med Inc.

            17.3.9.1. Overview

            17.3.9.2. Product Portfolio

            17.3.9.3. Sales Footprint

            17.3.9.4. Strategy Overview

18. Assumptions and Acronyms Used

19. Research Methodology

Recommendations

Healthcare

Vascular Closure Devices Market

September 2017

REP-GB-1809

September 2023

321 pages

Healthcare

Vascular Ulcer Treatment Market

July 2017

REP-GB-4294

July 2023

306 pages

Healthcare

Vascular Imaging Systems Market

September 2024

REP-GB-2346

Upcoming

Explore Healthcare Insights

View Reports
Future Market Insights

Non-Vascular Stents Market